News

The latest on lung cancer and the registry

Registry News

Your Data Moves Research Forward — The Registry’s Immunotherapy Survey Data is Presented

This month we are excited to announce that a summary of interim data was submitted and accepted as a poster for the Society for Immunotherapy of Cancer 33rd Annual Conference, held on November 7-11th, 2018. If you participated in our Immunotherapy Questionnaire, your anonymous data has directly impacted medical research - thank you! Read more about our study and its findings here.

Read more

New 2nd or 3rd Line Treatment for ALK+

Thank you for your participation in the Bonnie J. Addario Lung Cancer Registry! This month we have exciting news to share with our ALK+ patients:

Read more

New First-line Treatment for EGFR Patients

Thank you for your participation in the Bonnie J. Addario Lung Cancer Registry! This month we have exciting news to share with our EGFR patients:

Read more

Online Support Group Joins Forces with Registry to Advance Research

This month, we are excited to announce our partnership with the ALK Positive Facebook Support Group! By uniting our missions, more data means greater potential for patient-driven research.

Read more

News for Patients with Small Cell Lung Cancer - New FDA Approval

Thank you for your participation in the Bonnie J. Addario Lung Cancer Registry! This month, we are pleased to share exciting updates and opportunities within the Lung Cancer Registry and the greater cancer communities:

Read more

Announcing ROS1-fusion Research Study: Now Enrolling Patients Like You

Thank you for your participation in the Lung Cancer Registry! This message is coming to you because you indicated you have the ROS1 mutation.

Read more